Short Interest in Gelteq Limited (NASDAQ:GELS) Drops By 86.9%

Gelteq Limited (NASDAQ:GELS) was the recipient of a significant decrease in short interest in December. As of December 15th, there was short interest totaling 40,613 shares, a decrease of 86.9% from the November 30th total of 309,448 shares. Based on an average daily trading volume, of 96,833 shares, the short-interest ratio is presently 0.4 days. Currently, 0.4% of the shares of the company are sold short. Currently, 0.4% of the shares of the company are sold short. Based on an average daily trading volume, of 96,833 shares, the short-interest ratio is presently 0.4 days.

Gelteq Price Performance

Gelteq stock traded down $0.00 during trading on Thursday, reaching $0.87. The company had a trading volume of 9,774 shares, compared to its average volume of 96,301. The firm’s 50-day simple moving average is $1.07 and its 200 day simple moving average is $1.40. Gelteq has a 1-year low of $0.77 and a 1-year high of $4.11.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Gelteq stock. Susquehanna International Group LLP purchased a new position in Gelteq Limited (NASDAQ:GELS) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 41,550 shares of the company’s stock, valued at approximately $57,000. Susquehanna International Group LLP owned approximately 0.44% of Gelteq at the end of the most recent quarter.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Gelteq in a research report on Monday. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, Gelteq presently has an average rating of “Sell”.

Gelteq Company Profile

Gelteq Inc is a biotechnology company which specializes in the formulation, development and manufacturing of ingestible gel platform designed for nutrient and drug delivery. The Company is focused on advancing and commercializing its delivery solutions within core verticals pharmaceuticals, over-the-counter medications, nutraceuticals, animal medications and sports nutrition. Gelteq Inc is based in NEW YORK.